TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma
Xiao Ming Wang, Yuping Zhang, Rahul Mannan, Stephanie L. Skala, Roshni Rangaswamy, Anya Chinnaiyan, Fengyun Su, Xuhong Cao, Sylvia Zelenka-Wang, Lisa McMurry, Hong Xiao, Daniel E. Spratt, Ankur R. Sangoi, Lina Shao, Bryan L. Betz, Noah A. Brown, Satish K. Tickoo, Jesse K. McKenney, Pedram Argani, Sounak Gupta, Victor E. Reuter, Arul M. Chinnaiyan, Saravana M. Dhanasekaran, Rohit Mehra
Topics & Concepts
TFEBTFE3Microphthalmia-associated transcription factorRenal cell carcinomaChromophobe cellBiologyFluorescence in situ hybridizationPathologyIn situ hybridizationBiomarkerClear cellCancer researchMedicineGene expressionGeneGeneticsTranscription factorPromoterChromosomeRenal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancers